Literature DB >> 10459903

How should age affect management of acute myocardial infarction? A prospective cohort study.

K Barakat1, P Wilkinson, A Deaner, D Fluck, K Ranjadayalan, A Timmis.   

Abstract

BACKGROUND: About 75% of patients with acute myocardial infarction are older than 70 years, but patients in this age group are commonly treated less vigorously than younger patients. This differential treatment may partly reflect clinicians' misconceptions about the outlook of such patients, and the importance of age in clinical decisions. We examined how age does and should affect the management of patients and risk stratification in acute myocardial infarction.
METHODS: In this prospective cohort study, we recruited 1225 consecutive patients admitted with acute myocardial infarction to a district general hospital in east London. The primary endpoint was death. We used tabulation and regression methods to analyse the association between age group and clinical variables.
FINDINGS: Patients aged 70 years or older took a longer time to arrive in hospital and were less likely to receive thrombolysis or discharge beta-blockers than patients younger than 60 years: odds ratio 0.63 (95% CI 9.45-0.88) for thrombolysis and 0.25 (0.16-0.37) for beta-blockade, adjusted for sex, diabetes, previous acute myocardial infarction, Q wave infarction, and left-ventricular failure. Left-ventricular failure was the strongest independent predictor of death within 1 year of infarction with a hazard ratio of 4.76 (3.53-6.43), adjusted for age, sex, diabetes, and Q wave infarction. Patients aged 70 years or older without left-ventricular failure had significantly better survival at 1 year after acute myocardial infarction than patients under 60 years with left-ventricular failure. 70.8% (62.2-78.2) of the older patients who survived to hospital discharge were still alive 3 years later.
INTERPRETATION: Elderly patients with acute myocardial infarction were treated less vigorously than younger patients. The prognosis of acute myocardial infarction, however, was substantially affected by the development of left-ventricular failure and other clinical indices, such that many older patients had a better outlook than younger patients with adverse clinical factors. In planning risk-based management, consideration of age independently of clinical status is inappropriate.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Substances:

Year:  1999        PMID: 10459903     DOI: 10.1016/S0140-6736(98)07114-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

1.  Treatment of myocardial infarction should be audited before heart failure clinics are set up.

Authors:  A D Timmis
Journal:  BMJ       Date:  1999-07-10

2.  Acute coronary syndromes: risk stratification.

Authors:  A Timmis
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

3.  Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications.

Authors:  A Bowling; M Bond; D McKee; M McClay; A P Banning; N Dudley; A Elder; A Martin; I Blackman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

4.  Procedural and long-term outcome of primary percutaneous coronary intervention in octogenarians.

Authors:  L A A Moonen; M van 't Veer; N H J Pijls
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

Review 5.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

6.  Honour your father and mother: ageism in medicine.

Authors:  Ann Bowling
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

7.  Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches.

Authors:  Wilma Denneboom; Maaike G H Dautzenberg; Richard Grol; Peter A G M De Smet
Journal:  Br J Gen Pract       Date:  2007-09       Impact factor: 5.386

8.  Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel.

Authors:  Wilma Denneboom; Maaike G H Dautzenberg; Richard Grol; Peter A G M De Smet
Journal:  Br J Gen Pract       Date:  2006-07       Impact factor: 5.386

9.  Interventional treatment and outcome in elderly patients with stable coronary artery disease. Results from the German ALKK registry.

Authors:  H Rittger; M Hochadel; S Behrens; K E Hauptmann; R Zahn; H Mudra; J Brachmann; U Zeymer
Journal:  Herz       Date:  2013-05-29       Impact factor: 1.443

Review 10.  Administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention.

Authors:  Sadegh Ali-Hassan-Sayegh; Seyed Jalil Mirhosseini; Azadeh Shahidzadeh; Parisa Mahdavi; Mahbube Tahernejad; Fatemeh Haddad; Mohammad Reza Lotfaliani; Anton Sabashnikov; Aron-Frederik Popov
Journal:  Indian Heart J       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.